Search results
Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoRoyalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript May 9, 2024 Royalty Pharma plc...
Earnings call: Vanda Pharmaceuticals reports mixed Q1 results, plans growth
Investing.com· 6 days agoVanda (NASDAQ: VNDA ) Pharmaceuticals Inc. (VNDA) discussed its performance in the first quarter of...
Exploring Three Dividend Stocks On Euronext Paris
Simply Wall St. via Yahoo Finance· 1 day agoAmidst a backdrop of rising optimism in European markets, where indices like France's CAC 40 have recently seen significant gains, investors are...
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
WFRV 5 Green Bay· 5 days agoCelltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale ...
Stem cell injections in Mexico can be hazardous. Report identifies US victims.
USA TODAY via Yahoo News· 6 days agoIt doesn’t appear there’s any investigation into a possible outbreak, he added. Over a...
Myalgia (Muscle Pain)
Health via Yahoo News· 5 days agoHowever, the goal of treatment—regardless of the underlying cause is to reduce muscle pain. Treatments for common cause of myalgia may include: Cause of...
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
WTNH-TV New Haven· 7 days ago"During the first quarter and subsequent period, we have continued to advance both the phase 2 CALLIPER trial in patients with progressive multiple sclerosis</ ...
Q1 2024 Royalty Pharma PLC Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoFrexalimab significantly reduced disease activity, as measured by MRI, and the clinical relapse rate was close to 0 at 48 weeks. Importantly, the treatment was well tolerated ...
New AI tool to detect gender-related differences in brain structure
Investing.com· 1 day agoNew AI tool to detect gender-related differences in brain structure
Vanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Reve
Guru Focus· 5 days agoVanda Pharmaceuticals Inc (VNDA, Financial) disclosed its financial outcomes for the first quarter of 2024 on May 8, 2024, through its 8-K filing. The company, known for its focus on developing ...
